The PKCβ selective inhibitor, enzastaurin (LY317615), inhibits growth of human lymphoma cells.

被引：0
|
作者：
Rossi, RM [1 ]
Henn, AD [1 ]
Conkling, R [1 ]
Guzman, ML [1 ]
Bushnell, T [1 ]
Harvey, J [1 ]
Fisher, RI [1 ]
Jordan, CT [1 ]
机构：
[1] Univ Rochester, Sch Med, Ctr Canc, Rochester, NY USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1483
引用
收藏
页码：427A / 427A
页数：1
相关论文
共 50 条
  • [1] Inhibition of Human Lymphoma Cell Growth by the PKC-Beta Selective Inhibitor Enzastaurin (LY317615) in Combination with Multiple Therapeutic Agents
    Rossi, Randall M.
    Balys, Marlene
    Franklin, Dean
    Grose, Valerie
    Fisher, Richard I.
    Jordan, Craig
    BLOOD, 2008, 112 (11) : 565 - 566
  • [2] Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma
    Verdelli, D.
    Nobili, R. L.
    Civallero, M.
    Cosenza, M.
    Todoerti, K.
    Bertacchini, J.
    Lombardi, L.
    Marmiroli, S.
    Federico, M.
    De Pol, A.
    Lambertenghi-Deliliers, G.
    Tassone, P.
    Neri, A.
    Sacchi, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 258 - 258
  • [3] The oral PKC-beta inhibitor Enzastaurin (LY317615) inhibits proliferation and induces apoptosis in multiple myeloma cell lines
    Verdelli, D.
    Nobili, L.
    Todoerti, K.
    Lombardi, L.
    Marmiroli, S.
    Civallero, M.
    Cosenza, M.
    Bertacchini, J.
    Lambertenghi-Deliliers, G.
    Neri, A.
    Sacchi, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 137 - 137
  • [4] Antitumor activity of Enzastaurin (LY317615) in human tumor xenografts in vitro
    Maier, A.
    Fiebig, H. H.
    Thornton, D.
    Lahn, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 186 - 186
  • [5] ENZASTAURIN (LY317615), A PROTEIN KINASE C BETA SELECTIVE INHIBITOR, ENHANCES ANTIANGIOGENIC EFFECT OF RADIATION
    Willey, Christopher D.
    Xiao, Dakai
    Tu, Tianxiang
    Kim, Kwang Woon
    Moretti, Luigi
    Niermann, Kenneth J.
    Tawtawy, Mohammed N.
    Quarles, Chad C.
    Lu, Bo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05): : 1518 - 1526
  • [6] The Protein Kinase C Beta Selective Inhibitor, Enzastaurin (LY317615), Enhances Anti-Angiogenic Effect of Radiation
    Willey, Christopher
    Xiao, Dakai
    Tu, Tianxiang
    Kim, Kwang Woon
    Moretti, Luigi
    Niermann, Kenneth
    Tawtawy, Mohammed
    Quarles, Chad
    Lu, Bo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 614 - 614
  • [7] Enzastaurin (LY317615.HCl), a selective PKC beta inhibitor, suppresses human lung cancer cells in vitro and in vivo: a pharmacodynamic study
    Chan, Daniel C.
    Chen, Victor J.
    Zhang Zhiyong
    Zheng Di
    Dulude, Alexandra
    Nakajima, Eji
    Helfrich, Barbara
    Hirsch, Fred
    Clay, Michael P.
    Ma, Doreen
    Bunn, Paul A., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S460 - S460
  • [8] The protein kinase C beta (PKCβ) inhibitor enzastaurin HCl (LY317615) augments chemosensitivity of multiple myeloma (MM) cells to dexamethasone and the proteasome inhibitor bortezomib.
    Suvannasankha, A
    Xu, DW
    Abonour, R
    BLOOD, 2004, 104 (11) : 179B - 179B
  • [9] Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
    Rizvi, Mujahid A.
    Ghias, Kulsoom
    Davies, Katharine M.
    Ma, Chunguang
    Weinberg, Frank
    Munshi, Hidayatullah G.
    Krett, Nancy L.
    Rosen, Steven T.
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) : 1783 - 1789
  • [10] Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression'
    Verdelli, Donata
    Nobili, Lucia
    Todoerti, Katia
    Intini, Daniela
    Cosenza, Maria
    Civallero, Monica
    Bertacchini, Jessika
    Deliliers, Giorgio Lambertenghi
    Sacchi, Stefano
    Lombardi, Luigia
    Neri, Antonino
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (01) : 23 - 30
12345